26 3 hours ago Healthcare Stocks Recce Pharmaceuticals (ASX:RCE) Crashes 13% Despite $8m Raise and Middle East Licensing Deal KEY POINTS Recce raised A$4 million from institutions at A$0.40 a share and opened a share purchase plan to raise up to A$4 million more, for a target of… ByUjjwal Maheshwari